The number of individuals who want to be infected as part of vaccine development continues to grow despite coronavirus emerging as the most fatal contagious disease.
A global advocacy group has registered over 15,000 volunteers who are ready to be transmitted with the pathogen as part of the vaccine formation trials.
The ‘COVID-19 Human Challenge Trials’, launched by global advocacy group 1 Day Sooner has invited volunteers from all parts of the world to register for upcoming human vaccine trials.
The human trials of COVID-19 vaccine are still at a nascent stage and will require approval from the respective governments to allow their nationals to be exposed to the pathogen.
In the United States, the Federal Drug Authority (FDA) is yet to decide on whether human trials would be permitted.
The FDA has so far been approached by three pharmaceutical companies like Pfizer, Inovio and Moderna – for vaccine trials. The trio have conducted phase one of the clinical trials and have not revealed whether they have sought an FDA approval for human trials.
The London-based hVIVO and Switzerland-based SGS are two leading clinical research organisations who are pursuing human trials to expedite the vaccine formation. The two companies, along with an array of global advocates backing their cause, called the human trials a necessary to save thousands of lives that would be lost due to delay in vaccine development.